bleeding disorders treatment market
Healthcare Services

Global Bleeding Disorders Treatment Market Opportunities And Strategies 2023

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s bleeding disorders treatment market report forecasts the bleeding disorders treatment market size to grow to $20.65 Billion by 2027, with a CAGR (compound annual growth rate) of more than 8%.

Learn More On The Bleeding Disorders Treatment Market Report 2023 –

Bleeding Disorders Treatment Market Size Forecast
The global bleeding disorders treatment market is expected to grow from $13.74 billion in 2022 to $15.07 billion in 2023 at a compound annual growth rate (CAGR) of 9.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The bleeding disorders treatment market size is expected to grow to $20.65 billion in 2027 at a CAGR of 8.2%.

North America held the largest bleeding disorders treatment market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Bleeding Disorders Treatment Market Driver ­– Increase In The Number Of Diagnosed Hemophilia Patients
For instance, in August 2020, according to the World Federation of Hemophilia, a Canada-based international, non-profit organization, in 2020 the total number of people with bleeding disorders was 3,47,026 the number of people with Hemophilia was 2,09,614, and people with hemophilia A was 1,65,379 and people suffering with hemophilia B accounted for 33,076 across the world. Therefore, the increasing number of diagnosed hemophilia patients is driving the growth of the bleeding disorders treatment market.

Request for A Sample Of The Global Bleeding Disorders Treatment Market Report:

Key Bleeding Disorders Treatment Market Trend – Technological Advancement
Major companies operating in the bleeding disorder treatment sector is focused on developing innovative technologies to sustain their position in the market. For instance, in 2021, the University of Oslo, a Norway-based public research university, developed a new technology called super albumin that can lead to the development of long-acting medications and have significant implications for people with hemophilia. The University’s research team has created a novel biomedical technology that can be used to make coagulation factors that have a much longer half-life than those that are currently available. An in-depth analysis of a biological mechanism serves as the starting point. Using this knowledge, they were able to create super albumin, a protein variant that can be combined with protein-based medications to prolong their bloodstream half-life.

Bleeding Disorders Treatment Market Segment
1) By Treatment: Desmopressin (DDAVP), Hormone Replacement Therapy, Contraceptives, Anti-Fibrinolytic or Clot-Stabilizing Drugs, Fibrin Sealants, Drugs Applied To Cuts, Pipeline Analysis
2) By Disease Type: Hemophilia A, Hemophilia B, Von willebrand disease, Liver disease, Other Disease Types
3) By End User: Hospitals, Clinics, Speciality Clinics, Research Institutes, Other End Users

Bleeding Disorders Treatment Market Major Players and Strategies
Major players in the bleeding disorders treatment market are AbbVie Inc., Bayer AG, Novo Nordisk A/S, Pfizer Inc., Biogen, CSL Behring, Grifols S.A., Octapharma AG, BDI Pharma Inc., Ferring Pharmaceuticals, Xenetic Biosciences, Sanofi S.A., Alnylam Pharmaceuticals Inc., and Novartis AG.

In October 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology corporation, acquired Global Blood Therapeutics, Inc. (GBT) for an undisclosed amount. The acquisition aimed at utilizing the GBT portfolio to quicken discovery and provide numerous possible best-in-class medicines to sickle cell disease patients. Global Blood Therapeutics, Inc. is a US-based biopharmaceutical company specializing in treatment of blood disorders.

The Bleeding Disorders Treatment Global Market Report 2023 covers regional data on bleeding disorders treatment market size, bleeding disorders treatment market trends and drivers, opportunities, strategies, and bleeding disorders treatment market competitor analysis. The countries covered in the bleeding disorders treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Bleeding disorders are a group of diseases caused due to the inability of the blood to clot properly. Symptoms of bleeding disorders include extended bleeding after surgery, injury, menstruation, or trauma. The treatment is used to either stop or reduce the frequency of bleeding episodes.

View More Reports Related To The Bleeding Disorders Treatment Market –
Anemia And Other Blood Disorder Drugs Global Market Report 2023
Blood Transfusion Diagnostics Global Market Report 2023
Patient Blood Management Global Market Report 2023

Contact us at:
The Business Research Company:
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
Global Market Model:
Found this article helpful? Share it on: